<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sun, 12 Apr 2026 07:41:38 -0400--><rss version="2.0">
    <channel>
        <title>Inhibitor Therapeutics, Inc. (INTI) SEC Filings</title>
        <link>https://investors.inhibitortx.com/sec-filings/quarterly-reports/rss</link>
        <description>Inhibitor Therapeutics, Inc. (INTI) - Quarterly Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_5a8cb0b9c83c9803ac6e80d95e72f0b2/inhibitortx/files/theme/images/logo-sm.png</url>
                <title>Inhibitor Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-25-022178/0001493152-25-022178.pdf</link>
                <pubDate>Thu, 13 Nov 25 00:00:00 -0500</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-25-022178/0001493152-25-022178.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-023465/0001641172-25-023465.pdf</link>
                <pubDate>Wed, 13 Aug 25 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-023465/0001641172-25-023465.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-010110/0001641172-25-010110.pdf</link>
                <pubDate>Wed, 14 May 25 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001641172-25-010110/0001641172-25-010110.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-044473/0001493152-24-044473.pdf</link>
                <pubDate>Tue, 12 Nov 24 00:00:00 -0500</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-044473/0001493152-24-044473.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-030381/0001493152-24-030381.pdf</link>
                <pubDate>Tue, 06 Aug 24 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-030381/0001493152-24-030381.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-018805/0001493152-24-018805.pdf</link>
                <pubDate>Mon, 13 May 24 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-24-018805/0001493152-24-018805.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-23-040351/0001493152-23-040351.pdf</link>
                <pubDate>Mon, 13 Nov 23 00:00:00 -0500</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-23-040351/0001493152-23-040351.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-23-027740/0001493152-23-027740.pdf</link>
                <pubDate>Fri, 11 Aug 23 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-23-027740/0001493152-23-027740.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-23-016967/0001493152-23-016967.pdf</link>
                <pubDate>Mon, 15 May 23 00:00:00 -0400</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001493152-23-016967/0001493152-23-016967.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[10-Q - Quarterly report pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2]]></description>
                <link>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-22-284610/0001193125-22-284610.pdf</link>
                <pubDate>Mon, 14 Nov 22 00:00:00 -0500</pubDate>
                <guid>https://investors.inhibitortx.com/sec-filings/all-sec-filings/content/0001193125-22-284610/0001193125-22-284610.pdf</guid>
                                                                            </item>
            </channel>
</rss>